EP Multibagger Stock - Aug 2026
Latest News

USFDA to lift import ban from Divis Lab

As per Divis Lab, it was informed by USFDA that it will lift the Import Alert 66-40 and will move to close out the warning letter issued to the company’s Unit-II at Chippada, Visakhapatnam.

Earlier this year in March, the USFDA issued an import alert under clauses 99-32 and 66-40 to the company’s Visakhapatnam unit following an audit between 29 November and December 6, 2016.

As per the information on the USFDA’s website, import alert 66-40 is issued to companies which do not comply with good manufacturing practices.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Click here to check market prediction for next trading session.




📰
News
📈
Prediction
📊
FII / DII
💼
Portfolio 2026